The SURMOUNT-4 trial demonstrated that participants who discontinued tirzepatide after initial weight loss regained significant weight (approximately 14% regain over 52 weeks following randomized withdrawal), while those continuing treatment maintained their weight loss, confirming ongoing medication efficacy
Cureus J Med Sci 2022;14:e25134
Helps recycle natural antioxidants involved in liver metabolism
Exerccios fsicos, uma alimentao rica em fibras, o consumo adequado de protenas e a prtica da ordem correta das refeies so formas de estimular a produo desse hormnio sem a necessidade de suplementao
Cross-National Research to Understand Cultural Differences The authors propose a multinational research initiative, currently involving Brazil, the US, Denmark, and Japan, to examine how off-label GLP-1 RA use manifests across different societies, where cultural contexts shape distinct motivations
MacIsaac RJ, Deed G, DEmden M, Ekinci EI, Hocking S, Sumithran P, Rasalam R (2023) Challenging clinical perspectives in type 2 diabetes with tirzepatide, a first-in-class twincretin